Concepedia

Author

Alfonso Valle

Centro de Investigación en Red en Enfermedades CardiovascularesORCID

Also Known As

A VALLE, A Valle, A. Valle, A. Valle-Munoz, A. Valle-Muñoz, ALFONSO VALLE, Alberto del Valle, Aldo Maggioni, Alejandro Polti del Valle, Alfonso Muñoz

86

Publications

1.3K

Citations

14

H-Index

16

Concepts

All Affiliations

Centro de Investigación en Red en Enfermedades CardiovascularesCentro de Investigación Biomédica en RedUniversitat de ValènciaHospital General Universitario De ValenciaHospital Marina Baixa
AV

About

Alfonso Valle is an author at Centro de Investigación en Red en Enfermedades Cardiovasculares specializing in medicine, thrombosis, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

44

2

Immunology

1

1

14

3

Pathology

1

1

14

4

Pharmacology

1

1

30

5

Clinical Trials

1

1

30

Alfonso Valle

×

11

Publications

456

Citations

11

H-Index

YearCitations

Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction

Patricia Palau, Julia Seller, Eloy Domínguez,

Journal of the American College of Cardiology

2021

204

Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure

Alfonso Valle, Jordi Estornell-Erill, Carlos Soriano-Navarro,

European Journal of Echocardiography

2009

51

Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction ( <scp> DAPA‐VO <sub>2</sub> </scp> ): a randomized clinical trial

Patricia Palau, Martina Amiguet, Eloy Domínguez,

European Journal of Heart Failure

2022

50

Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials

Alberto Cordero, Moisés Rodríguez‐Mañero, Lorenzo Fácila,

Journal of Diabetes & Metabolic Disorders

2020

30

Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

Alberto Cordero, María Rosa Fernández Olmo, Gustavo Aníbal Cortez Quiroga,

Journal of Cardiovascular Pharmacology

2022

30

Effect of <scp>PCSK9</scp> inhibitors on remnant cholesterol and lipid residual risk: The <scp>LIPID‐REAL</scp> registry

Alberto Cordero, Ma Rosa Fernández del Olmo, Gustavo Aníbal Cortez Quiroga,

European Journal of Clinical Investigation

2022

21

A Delphi consensus on the management of oral anticoagulation in patients with non-valvular atrial fibrillation in Spain: ACOPREFERENCE study

Carlos Escobar, Xavier Borràs, Ramón Bover Freire,

PLoS ONE

2020

19

Renal Function Dynamics Following Co-Administration of Sacubitril/Valsartan and Empagliflozin in Patients with Heart Failure and Type 2 Diabetes

Rafael de la Espriella, Antoni Bayés‐Genís, Herminio Morillas,

ESC Heart Failure

2020

14

Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy

Edgardo Alania-Torres, Herminio Morillas-Climent, Alexandre García-Escrivá,

Frontiers in Cardiovascular Medicine

2021

14

Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure

Rafael de la Espriella, Martina Amiguet, Gema Miñana,

European Journal of Heart Failure

2022

12

Page 1